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SYSTEMS NEUROSCIENCE
NMDA receptors are heteromers constituted by different NR1, 
NR2, and/or NR3 subunits. The most common receptor combi-
nation consists of two NR1 subunits, which are obligatory for a 
functional receptor, and two NR2 subunits which confer differ-
ent physiological properties (Laube et al., 1998). NMDA recep-
tors expressed by MSSNs consist of NR1, NR2A, and/or NR2B 
subunits, thus allowing for diheteromeric (NR1/NR2A or NR1/
NR2B) and triheteromeric (NR1/NR2A/NR2B) receptors (Dunah 
and Standaert, 2003).
Mice with genetic deletion of specific NMDA receptor subu-
nits have been created (Ikeda et al., 1995; Sakimura et al., 1995; 
Kutsuwada et al., 1996; Mohn et al., 1999). Although deletion of 
some subunits (e.g., NR1 or NR2B) can be lethal, other genetic 
strategies can be used to examine the role of these subunits. This, 
in conjunction with the availability of relatively selective pharma-
cological antagonists, constitutes a powerful tool to begin dissecting 
the role of NMDA receptor subunits. The present study examined 
how specific NMDA receptor subunits sculpt NMDAR-mediated 
responses and how they affect DA modulation in MSSNs, particu-
larly the enhancement of NMDA currents by D1 receptor activation. 
In addition, we used mice expressing the reporter gene, enhanced 
IntroductIon
Glutamate and dopamine (DA) receptor interactions are vital to 
numerous functions including learning and memory, motor coor-
dination, and reward mechanisms (Calabresi et al., 2000; Surmeier 
et al., 2007; Schultz, 2010). When dysfunctional, these receptor 
interactions contribute to the manifestation of psychiatric and neu-
rodegenerative disorders (Andre et al., 2010b). Glutamatergic and 
DA inputs converge on the spines of striatal medium-sized spiny 
neurons (MSSNs) to regulate neuronal excitability (Bouyer et al., 
1984; Freund et al., 1984). DA differentially modulates excitatory 
inputs. Specifically, N-methyl-d-aspartate receptor (NMDAR)-
mediated responses are potentiated by D1 receptor (D1R) and 
attenuated by D2R activation (Cepeda et al., 1993; Snyder et al., 
1998; Chergui and Lacey, 1999; Levine et al., 1996b; Brady and 
O’Donnell, 2004; Tseng and O’Donnell, 2004). Modulation can 
occur through a variety of mechanisms including multiple trans-
duction pathways, voltage-gated Ca2+ channels, receptor subunit 
phosphorylation and mobilization, changes in receptor surface 
expression, and direct protein–protein coupling (Cepeda et al., 
1998; Snyder et al., 1998; Lee et al., 2002; Surmeier et al., 2007; 
Pascoli et al., 2011).
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Dopamine, via activation of D1 receptors, enhances N-methyl-d-aspartate (NMDA) 
receptor-mediated responses in striatal medium-sized spiny neurons. However, the role of 
specific NMDA receptor subunits in this enhancement remains unknown. Here we used 
genetic and pharmacological tools to dissect the contribution of NR1 and NR2A/B subunits 
to NMDA responses and their modulation by dopamine receptors. We demonstrate that D1 
enhancement of NMDA responses does not occur or is significantly reduced in mice with 
genetic knock-down of NR1 subunits, indicating a critical role of these subunits. Interestingly, 
spontaneous and evoked α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid (AMPA) 
receptor-mediated responses were significantly enhanced in NR1 knock-down animals, probably 
as a compensatory mechanism for the marked reduction in NMDA receptor function. The 
NMDA receptor subunits NR2A and NR2B played differential roles in D1 modulation. Whereas 
genetic deletion or pharmacological blockade of NR2A subunits enhanced D1 potentiation 
of NMDA responses, blockade of NR2B subunits reduced this potentiation, suggesting that 
these regulatory subunits of the NMDA receptor counterbalance their respective functions. In 
addition, using D1 and D2 receptor EGFP-expressing mice, we demonstrate that NR2A subunits 
contribute more to NMDA responses in D1-MSSNs, whereas NR2B subunits contribute more 
to NMDA responses in D2 cells. The differential contribution of discrete receptor subunits to 
NMDA responses and dopamine modulation in the striatum has important implications for 
synaptic plasticity and selective neuronal vulnerability in disease states.
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green fluorescent protein (EGFP) in direct (D1R-containing) and 
indirect (D2R-containing) pathway MSSNs to examine the relative 
contribution of NR2A/B subunits to NMDA responses and their 
modulation by dopamine receptor agonists.
MaterIals and Methods
All experimental procedures were performed in accordance with 
the United States Public Health Service Guide for Care and Use of 
Laboratory Animals and were approved by the Institutional Animal 
Care and Use Committee at the University of California, Los Angeles. 
Every effort was made to minimize pain and discomfort. Experiments 
were conducted on four groups of mice: (1) NR1 knock-down (KD; 
WT n = 4, age 98 ± 7 days; KD n = 6, age 100 ± 6 days), generated using 
homologous recombination in embryonic stem cells (Mohn et al., 
1999). This mouse line expresses only 5% of the subunit and is viable. 
(2) Mice with the NR2A subunit genetically removed (NR2AKO; 
slice: WT n = 31, age 37 ± 3 days; NR2AKO n = 28, 36 ± 3 days; 
acute dissociation: WT n = 34, age 37 ± 3 days; NR2AKO n = 44, age 
37 ± 2 days). (3) Mice with the NR2A subunit genetically removed 
and expressing EGFP under the control of the D1R promoter (D1 
WT n = 21, age 38 ± 3 days; D1 NR2AKO n = 15, age 38 ± 2 days), 
and (4) Mice with the NR2A subunit genetically removed and 
expressing EGFP under the control of the D2R promoter (D2 WT 
n = 15, age 38 ± 4 days; D2 NR2AKO n = 21, age 38 ± 2 days). EGFP 
mice were heterozygous. This is important as it was recently shown 
that D2-EGFP homozygous mice have significant increases in D2R 
expression (Kramer et al., 2011). Electrophysiological properties were 
examined in slices and acutely isolated MSSNs using whole-cell patch 
clamp recordings in voltage clamp mode.
BraIn slIce preparatIon
Mice were deeply anesthetized with halothane, killed by decapita-
tion, and the brains dissected and immediately placed in oxygenated 
ice cold low Ca2+ and high Mg2+ artificial cerebrospinal fluid (ACSF) 
containing (in mM) NaCl, 130; NaH
2
PO
4
, 1.25; KCl, 3; NaHCO
3
, 26; 
MgCl
2
, 5; CaCl
2
, 1, and glucose, 10. Coronal slices (350 μm) were 
cut and transferred to an incubating chamber containing ACSF 
(with 2 mM CaCl
2
 and 2 mM MgCl
2
) oxygenated with 95% O
2
–5% 
CO
2
 (pH 7.2–7.4, 290–310 mOsm, 25 ± 2°C). Following recovery, 
slices were placed on the stage of an upright microscope (Olympus 
BX51), submerged in continuously flowing ACSF (4 ml/min). All 
experiments were performed at room temperature.
Whole-cell patch clamp recordings in voltage clamp mode were 
obtained from MSSNs in the dorsolateral striatum visualized with 
the aid of infrared videomicroscopy (Cepeda et al., 1998). MSSNs 
were identified by somatic size and typical basic membrane proper-
ties (input resistance, membrane capacitance, and time constant). 
Series resistance was <25 MΩ. The patch pipette (4–6 MΩ) con-
tained the following solution (in mM): Cs–methanesulfonate 125, 
KCl 3, NaCl 4, MgCl
2
 1, MgATP 5, EGTA 9, HEPES 8, GTP 1, 
phosphocreatine 10, leupeptin 0.1, QX-314 4 (pH 7.25–7.3, osmo-
larity 280–290 mOsm). Passive membrane properties of MSSNs 
were determined by applying a depolarizing step voltage command 
(10 mV) and using the membrane test function integrated in the 
pClamp8 software (Axon Instruments, Foster City, CA, USA). This 
function reports membrane capacitance (in pF), input resistance 
(in MΩ) and time constant (in ms or μs).
Spontaneous EPSCs were isolated by holding the membrane at 
−70 mV and blocking GABA
A
 receptors with bicuculline methiodide 
(BIC, 20 μM). The amplitude, frequency, and kinetic properties of 
spontaneous EPSCs were measured using MiniAnalysis software 
(Synaptosoft Inc, Fort Lee, NJ, USA). Evoked EPSCs were recorded 
by stimulating the corpus callosum (0.01–1 mA square pulses, 0.1 ms 
duration) using a monopolar glass electrode placed 150–250 μm dor-
sal from the recording pipette. To isolate synaptic responses mediated 
by non-NMDA receptors, the GABA
A
 receptor blockers BIC (20 μM) 
or picrotoxin (100 μM) were applied, while CNQX or NBQX (10 μM) 
was applied to block non-NMDARs and isolate NMDAR responses. 
NMDAR–EPSCs were recorded either at +40 or −70 mV depend-
ing on the presence or absence of Mg2+ in the ACSF solution. Three 
responses (15 s between stimulations) were recorded and averaged 
at each intensity to construct input-output relationships.
acutely Isolated neurons
Detailed procedures have been published (Flores-Hernandez 
et al., 2002; Cepeda et al., 2008b). Briefly, slices were obtained as 
described above. After at least 1 h of incubation in oxygenated 
ACSF, the dorsal striatum was dissected, placed in an oxygenated 
cell-stir chamber (Wheaton, Millville, NJ, USA) and enzymatically 
treated for 20 min with papain (0.5 mg/ml, Calbiochem) at 35°C 
in a N-[2-hydroxyethyl] piperazine-N-[2-ethanesulfonic acid] 
(HEPES)-buffered Hank’s balanced salts solution (HBSS, Sigma 
Chemical) supplemented with (in mM) 1 pyruvic acid, 0.005 glu-
tathione, 0.1 NG-nitro-l-arginine, and 1 kynurenic acid (pH 7.4, 
300–310 mOsm). After enzymatic digestion, the tissue was rinsed 
with a low Ca2+ HEPES-buffered Na-isethionate solution contain-
ing (in mM) 140 Na-isethionate, 2 KCl, 2MgCl
2
, 0.1 CaCl
2
, 23 glu-
cose, and 15 HEPES (pH 7.4, 300–310 mOsm/l). Striatal slices were 
mechanically dissociated with fire-polished Pasteur pipettes. The 
cell suspension was then plated into a 35-mm nunclon Petri dish 
mounted on the stage of an upright microscope (Zeiss Axioscope, 
Thornwood, NY, USA) containing a HEPES-buffered salt solution.
Standard whole-cell patch clamp techniques were used to obtain 
voltage clamp recordings (Bargas et al., 1994). The internal solu-
tion consisted of (in mM) 175 N-methyl-d-glucamine (NMDG), 
40 HEPES, 2 MgCl
2
, 10 ethylene glycol-bis (β-aminoethyl ether)-
N,N,N′,N′-tetraacetic acid (EGTA), 12 phosphocreatine, 2 Na
2 
ATP, 
0.2 Na
2 
GTP, and 0.1 leupeptin (pH 7.25, 265–270 mOsm/l). The 
external solution consisted of (in mM) 135 NaCl, 20 CsCl, 3 BaCl
2
, 
2 CaCl
2
, 10 glucose, 10 HEPES, and 0.0003 tetrodotoxin (TTX; pH 
7.4, 300–310 mOsm/l). Recordings were obtained with an Axon 
Instruments 200A patch clamp amplifier and controlled by a compu-
ter running pClamp (v. 8.1; Axon Instruments, Foster City, CA, USA).
Drugs were applied through a pressure-driven fast perfusion 
system (SF-77B, Warner Instruments, Hamden, CT) synchronized 
by pClamp. Values for peak currents and peak current densities were 
calculated for all neurons. NMDA currents (3 s duration every 20 s) 
were evoked by applying different concentrations of the agonist 
while holding the cell at −70 mV.
drugs
The selective NR2A antagonist NVP-AAM077 (NVP, 0.001–1 μM) 
was a gift from Novartis; zinc (10–300 nM), another NR2A antag-
onist, was applied in the presence of 10 mM tricine to remove 
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peak current amplitude whereas in cells from NR1-KD mice the 
agonist produced little effects or even decreased peak current ampli-
tude (Figure 3A).
There also was decreased modulation of NMDAR-mediated 
responses by the dopamine D1 receptor agonist in isolated MSSNs 
(Figure 3B). The percent increase in NMDA responses was signifi-
cantly reduced in NR1-KD animals. No differences were found in 
D2 receptor modulation (Figure 3B, right bar graph).
role of nr2a suBunIts
The membrane properties of MSSNs in slice or after acute dis-
sociation were practically identical in control and NR2AKO mice. 
NMDAR-mediated EPSCs evoked by electrical stimulation were 
compared in slices. The membrane potential was held at +40 mV 
to remove the Mg2+ block of NMDARs and GABA
A
 and non-NMDA 
glutamate receptors were blocked with picrotoxin and CNQX, 
respectively. Responses from NR2AKOs (n = 18) had smaller peak 
amplitudes than those of WTs (n = 14) and statistically significant 
differences occurred at stimulation intensities between 0.8 and 
1.0 mA (p < 0.05; Figure 4A). Decay times were slower in cells 
from NR2AKOs than those of WTs at higher intensities as well 
(p < 0.05; Figure 4A right graph).
To isolate AMPAR-mediated responses, EPSCs were evoked at 
a holding potential of −70 mV in the presence of picrotoxin. Peak 
amplitudes were similar between cells from NR2AKOs (n = 18) 
and WTs (n = 14; Figure 4B). Moreover, ratios of NMDAR- to 
AMPAR-mediated currents were consistently smaller (p < 0.01) 
in NR2AKOs, indicating that smaller NMDAR–EPSC amplitudes 
were due to alterations in NMDARs and not due to differences in 
activation of excitatory inputs to MSSNs.
The effects of acutely blocking NR2A-containing NMDARs were 
also examined using a pharmacological approach. Following 5 min 
perfusion of NVP (0.1 μM), peak amplitudes of evoked NMDAR-
mediated EPSCs in WTs were decreased significantly compared 
to baseline responses (34.6 ± 3.8%, n = 12, p < 0.01) and decay 
times were increased (31.1 ± 13.9%, p < 0.05). In contrast, NVP 
had practically no effect on the amplitude of evoked responses in 
cells from NR2AKO mice (Figure 5). Taken together, these findings 
suggest that the NR2A subunit contributes significantly to synaptic 
NMDAR-mediated responses. Genetic deletion or acute pharma-
cological block of NR2A-containing NMDARs caused a reduction 
in peak amplitudes and prolonged the decay time of the response.
In dissociated WT cells increasing concentrations of NVP (0.001, 
0.01, 0.1, and 1 μM) or zinc (10, 30, 100, 300 nM) attenuated 
both peak and steady-state currents in a dose-dependent manner 
(Figures 6A,B). The peak component of the current was attenu-
ated by NVP more than the steady-state component (p < 0.05) 
whereas zinc attenuated steady-state currents more than peak cur-
rents (p < 0.05; Figure 6A graphs). This demonstrates that NR2A 
subunits contribute not only to synaptic NMDA responses but also 
to responses induced in the soma and proximal dendrites, where 
excitatory synaptic inputs are less abundant.
The effect of genetic deletion of NR2A subunits on NMDA 
responses induced by activation of mostly extrasynaptic recep-
tors located at or near the soma was then studied in dissociated 
MSSNs from WT and NR2AKO mice. Peak current and current 
density amplitudes evoked by increasing concentrations of NMDA 
ambient zinc. NR2B antagonists Ifenprodil (0.01–20 μM) was from 
Sigma; and Conantokin G (1 μM) from Peptides International. 
Stocks of NMDA (100 mM), NVP (1 mM), Ifenprodil (1 mM), 
6-Chloro PB (SKF 81297, 1 mM), and quinpirole (10 mM) were 
all dissolved in H
2
O and stored in the freezer until use.
data analysIs and statIstIcs
In the text, values are presented as means ± SEMs. Group means for 
all measures were compared using Student’s t-tests (for two group 
comparisons) and appropriately designed ANOVAs followed by 
suitable post hoc comparison tests (for multiple group comparisons) 
using SigmaStat software (SPSS, Chicago, IL, USA). Differences 
were considered statistically significant when p < 0.05.
results
role of nr1 suBunIts
As deletion of NR1 subunits is lethal, the contribution of these sub-
units to NMDAR-mediated responses was examined in NR1-KD 
mice (Mohn et al., 1999). MSSNs in slices from WT and NR1-KD 
mice displayed similar passive membrane properties including 
capacitance, input resistance and time constant (Table 1). As 
expected, NMDAR-mediated currents evoked by electrical stimu-
lation of cortical inputs were severely reduced in NR1-KD MSSNs 
(Figure 1A, left). Interestingly, evoked AMPAR-mediated currents 
were significantly increased, suggesting compensatory mechanisms 
(Figure 1A right). Similarly, the frequency of spontaneous EPSCs 
at a holding potential of −70 mV in the presence of BIC was sig-
nificantly increased in MSSNs from NR1-KD mice (Figure 1B). In 
addition, the kinetics of spontaneous synaptic events was changed. 
EPSCs displayed significantly faster rise and decay times, as well as 
reduced half-amplitude durations in cells from NR1-KD compared 
to control mice (Table 2).
In acutely isolated MSSNs, passive membrane properties were 
also similar (Table 1). Bath application of increasing concentrations 
of NMDA-induced inward currents but the amplitudes of these 
responses were significantly smaller in cells from NR1-KD mice 
(Figure 2A). The peak and current density amplitudes of AMPAR-
induced currents were also significantly increased in NR1-KD mice 
(Figure 2B), suggesting changes in postsynaptic AMPA receptors.
dopaMIne d1 receptor ModulatIon of nMda currents Is 
altered In nr1-Kd MIce
We have shown previously that activation of D1 receptors enhances 
synaptically evoked NMDA responses (Levine et al., 1996a). In 
cells from WT mice the D1 agonist SKF 81297 (1 μM) increased 
Table 1 | NR1-KD cells in slices: passive membrane properties.
 Cm (pF) Rm (MΩ) Tau (ms)
WT (n = 12) 78.8 ± 5.9 115.9 ± 14 2.3 ± 0.13
NR1-KD (n = 9) 80.4 ± 6.2 129.4 ± 11 2.1 ± 0.13
NR1-KD DiSSoCiATeD CellS: pASSive MeMbRANe pRopeRTieS
 Cm (pF) Rm (GΩ) Tau (μs)
WT (n = 23) 13.7 ± 0.4 2.2 ± 0.2 152 ± 11
NR1-KD (n = 24) 14.2 ± 0.6 1.9 ± 0.2 168 ± 19
Jocoy et al. D1 modulation of NMDA currents
Frontiers in Systems Neuroscience www.frontiersin.org May 2011 | Volume 5 | Article 28 | 3
 attenuation of NMDAR-mediated currents was significantly reduced 
in NR2AKOs (Figures 7A,B). Because synaptic inputs are mostly 
eliminated in dissociated MSSNs, these results suggest that either 
the NR2A subunit does not contribute significantly to mostly extra-
synaptic NMDA receptors, or that compensatory effects result from 
genetic ablation of this subunit. In support of the second alternative, 
application of Ifenprodil (1 and 10 μM), a NR2B antagonist, attenu-
ated peak currents from NR2AKOs significantly more in MSSNs 
from NR2AKO compared to WT mice (p < 0.05; Figure 7C).
To examine if there is a differential contribution of NR2A sub-
units in D1R- and D2R-expressing MSSNs, D1R-, or D2R EGFP 
mice were crossed to the NR2AKO mice, thereby creating double 
transgenic mice with EGFP labeling of D1R- or D2R-expressing cells 
with and without NR2A. In acutely isolated D1R-expressing MSSNs, 
(1, 10, 100, and 1000 μM) were similar in NR2AKO and WT mice 
(not shown). Moreover, EC
50
 values for mean peak current ampli-
tudes and current densities were also similar [45.3 ± 8.4 μM for 
WTs (n = 8) and 39.1 ± 3.4 μM for NR2AKOs (n = 16)]. However, 
in the presence of increasing concentrations of NVP or zinc, the 
FiGuRe 1 | (A) Traces show average NMDA and AMPAR-mediated responses 
evoked by cortical stimulation in Mg2+-free conditions and in the presence of 
non-NMDA (NBQX) and GABAA receptor blockers (BIC). Currents evoked by 
activation of NMDA receptors (left) were severely reduced in MSSNs from 
NR1-KD mice. In contrast, AMPA responses (right) were significantly increased. 
Cells were voltage clamped at −70 mV. Graphs indicate that at different 
stimulation intensities the NMDA currents were almost non-existent in NR1-KD 
cells (left), whereas the amplitude of AMPA currents was increased (right). 
Amplitude of AMPA currents was determined by subtraction of NMDA currents 
from the total current in the absence of glutamatergic antagonists. (b) 
Spontaneous excitatory postsynaptic currents (sEPSCs) recorded in MSSNs of 
∼3 month-old NR1-KD and control mice. Traces show sEPSCs recorded in the 
presence of a GABAA receptor antagonist (BIC, 20 μM) with membranes voltage 
clamped at −70 mV. Amplitude–frequency histograms for sEPSCs. Mean 
frequency of sEPSCs is indicated in the inset. *p < 0.05; **p < 0.01; 
***p < 0.001 in this and subsequent figures.
Table 2 | Kinetics of sepSCs in NR1-KD.
 Rise time (ms) Decay time (ms) Half-width (ms)
WT (n = 12) 2.9 ± 0.2 11.8 ± 0.9 13.8 ± 1.0
NR1-KD (n = 9) 2.1 ± 0.2** 7.8 ± 0.6*** 10.9 ± 0.7**
**p = 0.002; ***p = 0.0001.
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densities were similar between D2-NR2AKO and D2-WT MSSNs at 
all NMDA concentrations (Figure 8B). These data suggest a greater 
contribution of NR2A to D1R- compared to D2R-expressing MSSNs.
NMDAR-mediated peak current densities were consistently smaller in 
NR2AKOs than WTs across all concentrations (100, 500, and 1000 μM 
NMDA, p < 0.05; Figure 8A). In contrast, NMDAR-mediated current 
FiGuRe 2 | (A) In isolated MSSNs, bath application of increasing concentrations of NMDA-induced inward currents. As shown in the graphs, the amplitude of 
NMDAR-mediated peak and current densities was significantly smaller in cells from NR1-KD mice. (b) In contrast, peak and current densities induced by AMPA were 
significantly increased, suggesting compensatory mechanisms.
Jocoy et al. D1 modulation of NMDA currents
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Figure 9B left). In contrast, no significant differences in D2R atten-
uation of NMDAR-mediated currents occurred between D2-WT 
(n = 13) and D2-NR2AKO (n = 10) MSSNs (Figure 10 left). This 
indicates that D1R potentiation of NMDA responses is enhanced 
in the absence of NR2A subunits in D1R-expressing MSSNs.
role of nr2B suBunIts
As NR2BKO mice do not survive postnatally (Tovar et al., 2000), 
two NR2B subunit antagonists, Ifenprodil and Conantokin G were 
used to examine the contribution of NR2B subunits to NMDA 
responses and DA receptor modulation: NMDAR–EPSCs were 
isolated pharmacologically (Mg2+-free ACSF in the  presence of 
genetIc deletIon of nr2a enhances d1r potentIatIon of nMda 
responses
The selective D1R agonist SKF 81297 (1 μM) was used to examine 
the potentiation of NMDAR-mediated responses in isolated MSSNs 
from NR2AKO and control animals. In the entire population of 
MSSNs, without distinction of DA receptor-subtype expression, 
the percent increase was greater in NR2AKO mice than in WTs but 
the difference was not statistically significant (Figure 9A graph). 
However, after separating MSSNs by subtype using EGFP, NMDA 
currents in D1R-expressing neurons (n = 24) from NR2AKO mice 
displayed significant increases in potentiation compared to D1R-
expressing cells (n = 21) from WTs (p < 0.05; Figure 9A traces and 
FiGuRe 3 | (A) In cells from WT mice (left) the D1 agonist SKF 81297 
increased peak current amplitude of evoked NMDA responses, whereas in 
cells from NR1-KD mice (right) the agonist produced no change or decreased 
peak current amplitude. (b) There also was decreased modulation of NMDA 
responses by the dopamine D1 receptor agonist in isolated MSSNs. The 
percent increase in NMDA responses was significantly reduced in NR1-KD 
animals (left bar graph) whereas the decrease by a D2 agonist was unaffected 
(right bar graph).
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Figure 11B). Faster decay times tended to occur after either 
Ifenprodil or Conantokin application, although the difference 
did not reach statistical significance. Taken together, these find-
ings indicate that the NR2B subunit also contributes to synaptic 
NMDA responses.
BIC and CNQX). Ifenprodil (5 μM), a non-competitive NR2B 
antagonist, only slightly decreased peak NMDAR–EPSC ampli-
tudes 14.2 ± 4.2% (p < 0.05; Figure 11A). The competitive 
antagonist, Conantokin G (1 μM) significantly decreased peak 
NMDAR-mediated EPSCs in MSSNs (36.9 ± 8.1%, p < 0.05; 
FiGuRe 4 | (A) Representative traces of NMDAR-mediated evoked EPSCs 
from WT and NR2AKO MSSNs at different stimulation current intensities. 
Graphs are summary data illustrating that mean peak amplitudes of 
NMDAR–EPSCs are significantly smaller in MSSNs from NR2AKOs compared 
to those of WTs at higher stimulation intensities. In addition, deletion of 
NR2A results in slower mean decay times. (b) In contrast, genetic deletion of 
NR2A does not alter AMPAR-mediated EPSCs. Representative traces of 
evoked AMPAR–EPSCs from WT and NR2AKO MSSNs at different 
stimulation current intensities. Mean peak amplitudes of AMPAR–EPSCs are 
similar between genotypes at all intensities. Ratios of mean peak amplitudes 
of NMDAR- to AMPAR–EPSCs are significantly smaller in NR2AKOs 
than WTs.
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currents were potentiated regardless of the presence or absence 
of Ifenprodil. However, a significant decrease in potentiation by 
SKF 81297 (1 μM) was observed when Ifenprodil was present 
(20.8 ± 1.8%, n = 28 in the absence, and 14.1 ± 1.6%, n = 23 in 
the presence of Ifenprodil, p = 0.01; Figure 9B middle). These 
data suggest that the NR2B subunit finely tunes D1R modula-
tion; without NR2B, D1R modulation of NMDAR-mediated 
currents is dampened. In contrast, pharmacological blockade of 
NR2B subunits did not significantly affect D2R-mediated attenu-
ation of NMDAR-mediated responses with quinpirole (10 μM; 
Figure 10 middle).
effects of coMBIned genetIc and pharMacologIcal BlocK of 
nr2a and nr2B suBunIts on d1r ModulatIon
The combined effect of NR2A and NR2B subunits on D1R modu-
lation was analyzed by genetically deleting NR2A and pharmaco-
logically blocking NR2B-expressing NMDARs. Modulation was 
compared between D1R-expressing WT cells (n = 24), in which 
NR2A and NR2B subunits remained intact, and D1R-expressing 
cells in which NR2A was genetically deleted and NR2B subunits 
were blocked by Ifenprodil (n = 11). Interestingly, potentiation 
levels of NMDAR-mediated currents were similar for both groups 
(Figure 9B right). These data suggest that in the absence of NR2 
subunits, the presence of NR1 is enough to maintain normal D1R 
potentiation levels.
The combined role of NR2 subunits in D2R attenuation of 
NMDAR-mediated currents also was examined. D2R modula-
tion was compared between MSSNs with NR2 subunits intact 
(D2-WTs, n = 9) and MSSNs in which NR2A was genetically deleted 
and NR2B was blocked by Ifenprodil (D2-NR2AKO + Ifenprodil, 
n = 9). NMDAR-mediated currents from both groups were 
attenuated similarly by quinpirole, suggesting that the com-
bined presence or absence of NR2A and NR2B subunits does 
not play a significant role in D2R modulation of NMDA currents 
(Figure 10 right).
dIscussIon
The major findings of this study are that NR1, NR2A, and NR2B 
subunits differentially sculpt and modulate glutamatergic inputs 
in striatal MSSNs. Down-regulation of NR1 subunits in NR1-KD 
mice produces a significant reduction of NMDAR-mediated 
responses and removes the ability of D1 receptors to enhance 
these responses. Associated with these changes, AMPA recep-
tor function is increased in striatal slices and dissociated neu-
rons. Absence or pharmacological blockade of NR2A and NR2B 
subunits affect the amplitude and kinetics of NMDA responses 
and produce contrasting effects on D1 modulation. Whereas 
absence of NR2A subunits enhances NMDAR-mediated poten-
tiation, pharmacological blockade of NR2B subunits decreases 
this potentiation, suggesting that these subunits have different 
roles and counterbalance each other. In contrast, D2R modula-
tion of NMDA responses is largely unaffected by NR2A/B subu-
nits. Finally, we also demonstrate that the relative proportion 
of NR2 subunits is different in subpopulations of MSSNs, with 
D1 cells (direct pathway) functionally expressing relatively more 
NR2A-containing NMDARs and D2 cells (indirect pathway) 
functionally expressing more NR2B-containing NMDARs. The 
In isolated MSSNs increasing concentrations of Ifenprodil (0.1, 
1, and 10 μM) significantly attenuated both peak and steady-state 
NMDA currents. Steady-state currents were attenuated more that 
peak currents (p < 0.05; Figure 12A). The role of NR2B within 
MSSN subpopulations was examined by applying Ifenprodil to 
D1-WT and D2-WT cells. NMDAR-mediated peak current densi-
ties were blocked in both groups, however current densities from 
D2-WTs (n = 8) were slightly, but consistently, more sensitive 
to Ifenprodil than D1-WTs (n = 8, p < 0.05; Figure 12B). This 
difference in Ifenprodil sensitivity suggests that, functionally, 
levels of NR2B-containing NMDARs are greater in D2-WT than 
D1-WT cells.
pharMacologIcal BlocKade of nr2B suBunIts reduces d1r 
potentIatIon of nMda responses
To determine if D1R modulation of NMDAR-mediated currents 
is affected by the NR2B subunit, recordings from D1-WT MSSNs 
were made with and without Ifenprodil (1 μM). NMDAR-mediated 
FiGuRe 5 | (A) Representative evoked NMDAR-EPSCs from WT and NR2AKO 
MSSNs before (left) and after (right) 5 min application of NVP. (b) Graph on the 
left illustrates that NVP (0.1 μM) significantly attenuates mean peak amplitudes 
of NMDAR-EPSCs from WT cells only. Bar graph on the right demonstrates that 
mean peak amplitudes remain stable during a 5 min recording period in the 
absence of the NR2A antagonist.
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Dopamine D1 receptor modulation of NMDAR-mediated cur-
rents in NR1-KD mice showed significant deficits. Enhancement of 
NMDAR-mediated responses by D1 receptors in striatum is enacted 
through a number of intracellular signaling cascades including 
cAMP–PKA–DARPP32, Ca2+ conductances, and phosphorylation 
of NMDA receptor subunits (Snyder et al., 1998; Fiorentini and 
Missale, 2004; Cepeda et al., 2008a). Reduced expression of NR1 
subunits completely obliterated D1 receptor modulation, suggest-
ing that this subunit may represent a final common path for these 
signaling cascades.
The NR2A/B regulatory subunits confer different sensitiv-
ity to zinc and polyamines, open probability, deactivation time, 
and channel conductance, to name a few (Kohr, 2006). Although 
still controversial, it appears that NR2 subunit expression differs 
depending on receptor location with the most prominent contribu-
tion of NR2A-containing NMDARs at synaptic sites and NR2B-
containing NMDARs at both synaptic and extrasynaptic receptor 
locations. The present study provides some support for this idea, 
as genetic KO of NR2A subunits changed the kinetics of evoked 
synaptic responses.
D1 receptor potentiation of NMDA currents is altered by NR2 
subunit composition, but D2R attenuation of these currents is 
not. Genetic deletion of the NR2A subunit leads to enhanced 
D1R potentiation of NMDAR-mediated currents, suggesting 
fact that many of the findings could be demonstrated in slices 
and in isolated cell preparations is one of the strengths of the 
present study.
The NR1 subunit is obligatory for a functional NMDA recep-
tor. Thus, the reduction in NMDA receptor-mediated currents in 
MSSNs from NR1-KD mice was expected. However, the increase 
in AMPAR-mediated responses was unexpected and suggested 
compensatory mechanisms to counter deficits in NMDA recep-
tor function. While this effect could be the result of homeostatic 
mechanisms to balance such deficits, it could also reflect a limitation 
of the use of genetic knock-out or knock-down animals to examine 
the function of specific receptor subunits. The very low expression 
of NR1 subunits during development could have contributed to the 
changes in AMPA receptor function observed in the present study.
Spontaneous EPSCs displayed faster kinetics indicating that 
AMPA receptor subunit composition or glutamate transport-
ers may also have changed. However, it cannot be ruled out that 
the near absence of NR1 subunits contributed to faster EPSCs as 
NMDAR-mediated responses have slower kinetics than AMPA 
responses. Finally, in dissociated MSSNs responses to AMPA were 
increased in NR1-KD animals. Alterations in frequency and kinet-
ics of spontaneous EPSCs, as well as increased responsiveness to 
AMPA, suggest changes at both the circuit and receptor levels after 
know-down of NR1 subunits.
FiGuRe 6 | (A) Representative traces from a WT MSSN of NMDAR-mediated 
currents in the presence of increasing concentrations of NVP. Bar graphs 
summarize the decrease in peak and steady-state average NMDAR currents in 
WT MSSNs in the presence of increasing concentrations of NVP. Peak currents 
were attenuated more than steady-state currents at higher concentrations. 
(b) Representative traces of NMDAR-mediated currents from WT cells in the 
presence of increasing concentrations of zinc. Bar graphs illustrate the decrease 
in peak and steady-state average NMDAR-mediated currents in the presence of 
increasing concentrations of zinc. Steady-state currents were attenuated more 
than peak currents.
Jocoy et al. D1 modulation of NMDA currents
Frontiers in Systems Neuroscience www.frontiersin.org May 2011 | Volume 5 | Article 28 | 9
In contrast, the presence of the NR2B subunit enhances 
D1R potentiation. Genetic deletion of the NR2A subunit at 
NMDARs located at the soma and proximal dendrites leads to 
increased Ifenprodil sensitivity and pharmacological  blockade 
of NR2B-containing NMDARs reduces D1R potentiation. 
Interestingly, studies in the striatum and prefrontal cortex 
have demonstrated that activation of D1Rs leads to increased 
surface expression of the NR2B subunit, potentially explain-
ing the observed enhancement of NMDAR-mediated currents 
(Dunah and Standaert, 2001; Hallett et al., 2006). The  mechanism 
that the presence of the NR2A subunit normally counters D1R 
potentiation. Direct protein coupling is known to occur between 
the C-terminus of the D1R and the C-terminus of the NR2A 
subunit, and in the presence of PKA and PKC antagonists, this 
direct coupling causes a decrease in NMDAR-mediated cur-
rents (Lee et al., 2002; Lee and Liu, 2004). This attenuation of 
currents occurs because fewer NMDARs are expressed on the 
membrane. In NR2AKO mice, the NR2A subunit is missing, thus 
direct coupling between D1Rs and NR2A-containing NMDARs 
cannot occur.
FiGuRe 7 | (A) Traces of NMDAR-mediated currents from WT and NR2AKO 
isolated MSSNs in the presence of increasing concentrations of NVP 
demonstrate that attenuation of NMDAR-mediated currents by the antagonist is 
reduced in NR2AKOs. Graph shows that NVP decreases mean peak NMDAR-
mediated currents more in WT than in NR2AKOs. (b) Zinc attenuation of 
NMDAR-mediated currents is also reduced in NR2AKOs at most concentrations. 
(C) In NR2AKO MSSNs, the functional contribution of NR2B to NMDAR-
mediated currents is increased. Traces of NMDAR-mediated currents from WT 
(top) and NR2AKO (bottom) MSSNs in the presence of Ifenprodil. Graph 
illustrates increased Ifenprodil sensitivity in NR2AKO compared to WT MSSNs.
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the presence of cocaine (Liu et al., 2006). It is striking that despite 
the existence of D2-NR2B heteroreceptors, pharmacological block 
of NR2B-expressing receptors does not alter D2R modulation. 
Because these heteroreceptors appear to occur only under par-
ticular conditions, they may not play an important role in normal 
D2R modulation of NMDAR-mediated currents.
Prior studies examining NR2 subunit expression in striatum 
observed the presence of NR2A and NR2B subunits in MSSNs. 
However, conclusive data regarding the preferred expression of 
NR2 subunits between MSSNs of the direct (D1) and indirect (D2) 
pathways was not observed (Landwehrmeyer et al., 1995; Standaert 
et al., 1999). In the present study, significant functional differences 
in NR2 subunit composition of NMDARs were observed with 
D1R-containing cells expressing relatively greater NR2A subunit 
levels while D2R-containing cells express relatively greater NR2B 
subunit levels. Opposite results were observed by Fantin et al. 
(2007), concluding that NR2A subunits regulate D2 while NR2B 
subunits regulate D1 MSSNs. Differences in methodology could 
explain these opposing findings. One caveat of the present study 
is that only acutely isolated MSSNs were used for the NR2 subunit 
experiments. Thus, observed differences in NR2 subunit expres-
sion between D1R- and D2R-expressing MSSNs are applicable 
 responsible for this transfer of NMDARs from the intracellu-
lar membrane to the plasma membrane surface involves phos-
phorylation of NR2B subunits by tyrosine kinases (Dunah and 
Standaert, 2001; Dunah et al., 2004; Hallett et al., 2006; Gao 
and Wolf, 2008; Pascoli et al., 2011). Therefore, pharmacologi-
cal blockade of the NR2B subunit will prevent increased surface 
expression by D1R activation and the level of potentiation of 
NMDAR-mediated currents will decrease. Heteromeric com-
plexes consisting of NMDA and D1Rs are known to exist and 
these complexes increase the density of D1Rs at the postsynaptic 
density (Fiorentini and Missale, 2004).
It appears that NR2A and NR2B subunits maintain a balance, 
and when one of these subunits is missing or antagonized, the 
other predominates and the degree of D1R modulation becomes 
affected. However, when both NR2A and NR2B subunits are 
blocked, D1R modulation levels of NMDAR-mediated currents 
are similar to WT levels. Perhaps phosphorylation of NR1 subu-
nits is sufficient to allow renormalization of D1R potentiation 
(Snyder et al., 1998).
Interestingly, changes in NR2 subunit composition do not alter 
D2R modulation of NMDA currents. Direct protein–protein cou-
pling does occur between NMDARs and D2Rs, although only in 
FiGuRe 8 | (A) Traces of NMDAR-mediated currents from acutely isolated 
D1-WT and D1-NR2AKO MSSNs demonstrate a larger contribution of NR2A 
subunits to NMDA responses in D1R-expressing MSSNs. Line graph shows that 
genetic deletion of NR2A significantly decreases mean peak NMDAR-mediated 
current densities in D1R-expressing MSSNs. (b) In contrast, NR2A subunits 
contribute less to NMDA responses in D2R-expressing MSSNs. Representative 
traces of NMDAR-mediated currents from acutely isolated D2-WT and 
D2-NR2AKO MSSNs. Line graph illustrates that genetic deletion of NR2A does 
not significantly alter mean peak NMDAR-mediated current densities in 
D2R-expressing MSSNs.
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in the NR2 subunit ratio of another HD model leads to increased 
striatal neurodegeneration by overexpression of NR2B subunits, 
further emphasizing that changes in NR2 composition can exac-
erbate pathological conditions (Heng et al., 2009). The location 
of NR2 subunits also plays an important role. NR2A subunits are 
predominantly found at the synapse, whereas NR2B subunits occur 
at both synaptic and extrasynaptic sites. It has been shown that 
stimulation of synaptic NMDA receptors confers cell protection 
in mouse models of HD, whereas stimulation of NR2B-containing 
NMDA receptors at extrasynaptic locations is pro-apoptotic and 
detrimental for cell survival (Okamoto et al., 2009; Milnerwood 
et al., 2010).
NMDA receptors play an essential role in cognition and mood 
regulation. Blockade or deficits in NMDA receptor-function have 
been associated with the negative symptoms of schizophrenia 
(Olney et al., 1999). However, individual subunits appear to play 
different roles. In the NR1-KD mouse used in the present study, 
behavioral alterations similar to those observed in pharmacologi-
cally induced animal models of schizophrenia have been reported 
(Mohn et al., 1999; Ramsey, 2009). Cognitive deficits in NR1-KD 
mice could be compounded by the lack of D1 receptor potentia-
tion of NMDA responses. In contrast, NR2A subunit KO mice 
only to NMDARs located at the soma and proximal dendrites. 
These data do not provide information about the distribution of 
NR2A- and NR2B-containing NMDARs at distal dendrite loca-
tions on MSSN subpopulations.
Differences in NR2 subunit expression may play a key role in 
excitotoxicity and, therefore, could increase the overall vulner-
ability of subpopulations of MSSNs. Several pieces of evidence 
suggest that D1 MSSNs are less vulnerable to excitotoxicity than 
D2 MSSNs. D1 cells express greater levels of NR2A-containing 
NMDARs than D2 cells and these NMDARs have faster decay 
times (Monyer et al., 1994; Flint et al., 1997). As a result, Ca2+ 
flux is more restricted in D1 cells, potentially providing more 
protection for these cells. The combination of increased excit-
ability (Kreitzer and Malenka, 2007; Cepeda et al., 2008b; 
Gertler et al., 2008) and greater functional expression of NR2B-
containing NMDARs in D2 cells may increase their vulnerability 
to excitotoxicity.
The functional importance of NR2 subunit composition of 
NMDARs is highlighted by pathological conditions in which 
changes in subunit composition occur, including Huntington’s dis-
ease (HD). Alterations in NR2 subunit composition are observed in 
a mouse model of HD (Ali and Levine, 2006). Additionally, shifts 
FiGuRe 9 | (A) Bar graph shows that genetic deletion of NR2A does not 
significantly alter D1R-modulation of NMDAR-mediated currents in both D1R- 
and D2R-expressing cells. Traces on the right illustrate NMDAR-mediated 
currents in D1-WT and D1-NR2AKO MSSNs. The D1 agonist (PB) significantly 
potentiates NMDAR-mediated currents more in D1R-expressing cells from 
NR2AKOs. (b) The bar graph on the left illustrates that genetic deletion of NR2A 
significantly increases D1R potentiation of NMDA currents. The bar graph in the 
middle demonstrates that pharmacological block of NR2B-expressing NMDARs 
results in a significant decrease in D1R potentiation. The bar graph on the right 
illustrates that the combined genetic deletion of NR2A and pharmacological 
block of NR2B-expressing NMDARs does not significantly alter 
D1R modulation.
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to improve cognitive performance in attentional tasks (Kos et al., 
2011). The idea that NR2A and NR2B subunits play differen-
tial roles in synaptic plasticity remains controversial, and most 
studies indicate that both are required for long-term synaptic 
changes (Erreger et al., 2005; Fox et al., 2006; Schotanus and 
Chergui, 2008; Muller et al., 2009). The fact that their  interactions 
demonstrate a selective reduction in anxiety and depression, 
supporting a role of NR2A subunits in the modulation of emo-
tional behaviors (Boyce-Rustay and Holmes, 2006). Absence of 
the NR2A subunits in mice also leads to deficits in discrimination 
learning (Brigman et al., 2008), suggesting this subunit plays a 
role in synaptic plasticity. In contrast, NR2B antagonists appear 
FiGuRe 10 | The bar graph on the left illustrates that genetic deletion 
of NR2A does not significantly alter D2R attenuation of NMDAR-
mediated currents. The bar graph in the middle demonstrates that 
pharmacological block of NR2B-containing NMDARs does not significantly 
affect D2R modulation. The bar graph on the right shows that the 
combined genetic deletion of NR2A and pharmacological block of NR2B-
expressing NMDARs does not significantly alter D2R modulation of 
NMDAR-mediated currents.
FiGuRe 11 | (A) Representative traces of evoked NMDAR–EPSCs before and 
after 5 min application of the NR2B antagonist, Ifenprodil. Bar graph illustrates 
that Ifenprodil decreases mean peak amplitudes of NMDAR–EPSCs 
compared to baseline responses. (b) Representative traces of NMDAR–
EPSCs before and after 5 min application of the NR2B antagonist, Conantokin 
G. Bar graph shows that Conantokin G significantly decreases mean 
peak amplitudes of NMDAR–EPSCs in WT MSSNs compared to 
baseline responses.
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 completely eliminates NMDA responses and their modulation. 
NR2A/B subunits can affect amplitude and kinetics of the response 
and play contrasting roles in D1 receptor modulation. In addition, 
we demonstrate that in D1 receptor-containing MSSNs the NR2A 
subunit has a more prominent functional role, whereas in D2 recep-
tor-containing MSSNs the NR2B subunit predominates. This could 
have important implications for differential synaptic plasticity and 
neuronal vulnerability of MSSNs of the direct and indirect path-
ways. We have demonstrated that D1 receptor activation enhances 
NMDA responses (Cepeda et al., 1993; Andre et al., 2010a). If NR2A 
with D1 receptors are bidirectional lends support to the idea of 
specific functions of each subunit in synaptic plasticity, at least 
in striatum.
conclusIon
In conclusion, using genetic and pharmacological tools we provide 
evidence that NMDA receptor subunits differentially contribute 
to the sculpting of NMDA responses and their modulation by D1 
dopamine receptors in striatal MSSNs. The NR1 subunit is criti-
cal for both functions as down-regulation of this subunit almost 
FiGuRe 12 | (A) Pharmacological blockade of NR2B-expressing NMDARs with 
increasing concentrations of Ifenprodil reveals a contribution of these subunits 
to NMDAR-mediated currents in acutely isolated MSSNs. Bar graph illustrates 
the decrease in peak and steady-state mean NMDAR currents. Steady-state 
currents are attenuated more than peak currents. (b) NR2B subunits contribute 
more to D2R-than D1R-expressing MSSNs. Representative traces of 
NMDAR-mediated currents from D1-WT and D2-WT cells in the presence of 
increasing concentrations of Ifenprodil. Line graph illustrates that in both D1-WT 
and D2-WT MSSNs, NMDAR-mediated currents are blocked by Ifenprodil, but 
the sensitivity is greater in D2 cells.
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